Acornex aims to develop and commercialize, primarily through corporate partnerships, pharmaceutical products with improved bioavailability based on proprietary molecular carrier technology which help overcome various biomembrane barriers, especially in the areas of critical health needs.

BACKGROUND
Most drugs work by binding to intracellular targets such as enzymes, receptors, and DNA in the appropriate organs and tissues Thus, the drug must .....



 

PLATFORM TECHNOLOGY
The traditional drug delivery technology has been successful in developing controlled-release devices such as polymer-based caplets and mini-pumps, .....


 

THE ACORNEX ANSWER
One of the founders of Acornex has successfully designed and prepared novel molecular carrier vectors whose structures consist of a scaffold and an appropriate number ..... 


 

-